Zobrazeno 1 - 10
of 1 091
pro vyhledávání: '"K, Wynia"'
Autor:
Kyle C. Molina, Brandon J. Webb, Victoria Kennerley, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, David A. Mayer, Jennifer L. Peers, Seth Russell, Matthew K. Wynia, Neil R. Aggarwal, Adit A. Ginde
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background A trial performed among unvaccinated, high-risk outpatients with COVID-19 during the delta period showed remdesivir reduced hospitalization. We used our real-world data platform to determine the effectiveness of remdesivir on redu
Externí odkaz:
https://doaj.org/article/3e8ea79849a7468ea7505d78a68e5792
Autor:
Kyle C. Molina, Victoria Kennerley, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, David A. Mayer, Jennifer L. Peers, Seth Russell, Matthew K. Wynia, Neil R. Aggarwal, Adit A. Ginde
Publikováno v:
International Journal of Infectious Diseases, Vol 132, Iss , Pp 34-39 (2023)
ABSTRACT: Objectives: Bebtelovimab is an anti-SARS-CoV-2 monoclonal antibody active against Omicron lineage variants authorized to treat high-risk outpatients with COVID-19. We sought to determine the real-world effectiveness of bebtelovimab during t
Externí odkaz:
https://doaj.org/article/9ed277ad61dd4335a7963ed7c8a1c772
Autor:
Neil R. Aggarwal, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, David A. Mayer, Kyle C. Molina, Jennifer L. Peers, Seth Russell, Matthew K. Wynia, Adit A. Ginde
Publikováno v:
International Journal of Infectious Diseases, Vol 128, Iss , Pp 310-317 (2023)
ABSTRACT: Objectives: Sotrovimab effectively prevented progression to severe disease and mortality following infection with pre-Omicron SARS-CoV-2 variants. We sought to determine whether sotrovimab is similarly effective against SARS-CoV-2 Omicron v
Externí odkaz:
https://doaj.org/article/c23aa24013ca43e4b81a1fa46608b156
Autor:
David J. Douin, Adane F. Wogu, Laurel E. Beaty, Nichole E. Carlson, Tellen D. Bennett, Neil R. Aggarwal, David A. Mayer, Toan C. Ong, Seth Russell, Jeffrey Steele, Jennifer L. Peers, Kyle C. Molina, Matthew K. Wynia, Adit A. Ginde
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Neutralizing monoclonal antibodies (mAbs) are highly effective in reducing hospitalization and mortality among early symptomatic COVID-19 patients in clinical trials and real-world data. While resistance to some mAbs has since eme
Externí odkaz:
https://doaj.org/article/9243363dc9f34305a5f57b6c977b0775
Autor:
Mika K. Hamer, Chelsea Sobczak, Lindsey Whittington, Rachel L. Bowyer, Ramona Koren, Joel A. Begay, Hillary D. Lum, Adit A. Ginde, Matthew K. Wynia, Bethany M. Kwan
Publikováno v:
Journal of Clinical and Translational Science, Vol 7 (2023)
Abstract Introduction: Multi-level dissemination strategies are needed to increase equitable access to effective treatment for high-risk outpatients with COVID-19, particularly among patients from disproportionately affected communities. Yet assessi
Externí odkaz:
https://doaj.org/article/de21e0f512474f85b4dae8aeb3a85727
Autor:
Lindsey E. Fish, Tiffany Bendelow, Sarah Gardiner, Matthew K. Wynia, Bethany M. Kwan, Mika K. Hamer, Adit A. Ginde, Rebecca Hanratty
Publikováno v:
Journal of Clinical and Translational Science, Vol 7 (2023)
Abstract Introduction: Racial and ethnic minority groups have higher rates of SARS-CoV-2 infection, severe illness, and death; however, they receive monoclonal antibody (mAb) treatment at lower rates than non-Hispanic White patients. We report data
Externí odkaz:
https://doaj.org/article/6ca61e85e2e8497d9c35660f338bdf8b
Autor:
Abigail E. Lowe, Teck Chuan Voo, Lisa M. Lee, Kelly K. Dineen Gillespie, Christy Feig, Alva O. Ferdinand, Seema Mohapatra, David M. Brett-Major, Matthew K. Wynia
Publikováno v:
The Lancet Regional Health. Americas, Vol 16, Iss , Pp 100374- (2022)
Summary: Communicating public health guidance is key to mitigating risk during disasters and outbreaks, and ethical guidance on communication emphasizes being fully transparent. Yet, communication during the pandemic has sometimes been fraught, due i
Externí odkaz:
https://doaj.org/article/9262a6cfdfeb4e48b301aa69c6f79e4e
Publikováno v:
Journal of Military & Veterans' Health. Jul2022, Vol. 30 Issue 3, p49-55. 7p.
Publikováno v:
BMC Oral Health, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background It is unclear how many community-dwelling elderly (≥75 years) experience oral health problems (e.g. pain, dry mouth, chewing problems) and how they manage their dental care needs. This study aimed to assess self-reported oral he
Externí odkaz:
https://doaj.org/article/6c0d5b1af1154736a2ca970ef8d7c22c
Autor:
Bethany M Kwan, Chelsea Sobczak, Carol Gorman, Samantha Roberts, Vanessa Owen, Matthew K Wynia, Adit A Ginde, Griselda Pena-Jackson, Owen Ziegler, Lisa Ross DeCamp
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0274043 (2022)
BackgroundNeutralizing monoclonal antibody (mAb) treatment for COVID-19 prevents hospitalization and death but is underused, especially in racial/ethnic minority and rural populations. Reasons for underuse and inequity may include community member la
Externí odkaz:
https://doaj.org/article/91abd02354db4cc69c07c2593da9aa18